Kobayashi, Shin
Bando, Hideaki
Taketomi, Akinobu
Takamoto, Takeshi
Shinozaki, Eiji
Shiozawa, Manabu
Hara, Hiroki
Yamazaki, Kentaro
Komori, Koji
Matsuhashi, Nobuhisa
Kato, Takeshi
Kagawa, Yoshinori
Yokota, Mitsuru
Oki, Eiji
Komine, Keigo
Takahashi, Shinichiro
Wakabayashi, Masashi
Yoshino, Takayuki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (21lk0201148h0001)
Article History
Received: 20 February 2023
Accepted: 17 August 2023
First Online: 21 August 2023
Declarations
:
: The current study has been approved by the Institutional Review Board of National Cancer Center Hospital East (EPOC2101), and permission for conducting the study has been obtained from the IRB of all participating facilities. All procedures will be performed in accordance with the protocol, Declaration of Helsinki, governmental laws and regulations, and their revisions and related notifications. All patients are required to sign written informed consent.
: Not applicable.
: SK reports honoraria from Ono, Johnson & Johnson, and Asahi Surgical Robotics.HB reports research funding from Takeda, Daiichi Sankyo, and Sysmex, and honoraria from Takeda, Chugai, Taiho, and Eli Lilly.ES reports honoraria from Takeda, Merck, Eli Lily, and Chugai.MS reports honoraria from Eli Lilly, Takeda, Taiho, Ono, Yakult, and Merck.HH reports honoraria from Bayer, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Kyowa Hakko Kirin, Eli Lilly, Merck, MSD, Ono, Taiho, Takeda, and Yakult, having consulting or advisory roles in Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Dainippon Sumitomo, MSD, and Ono, and receiving research grants from ALX oncology, Amgen, Astellas, AstraZeneca, Bayer, BeiGene, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, Ono, and Taiho.KY reports honoraria from Chugai, Daiichi Sankyo, Yakult, Takeda, Bayer, Merck, Taiho, Eli Lilly, Sanofi, Ono, MSD, and Bristol-Myers Squibb.NM reports honoraria from Merk and research funding from Ono.YK reports honoraria from Chugai, Eli Lilly, Takeda, Bayer Yakuhin, Taiho, MSD, Ono, Yakult, Merck, and Sanofi.EO reports research funding from Guardant Health and honoraria from Ono, Takeda, Bayer, Chugai, Taiho, Eli Lilly, and Bristol-Myers Squibb.ST reports honoraria from Taiho and VIATRIS.AT, TT, KK, MY, TK, and MW have no conflicts to declare.TY reports research funding from Novartis Pharma, MSD, Sumitomo Dainippon, Chugai, Sanofi, Daiichi Sankyo, Parexel, and Ono.